SUZ12 and malignant peripheral nerve sheath tumor: Notably, a distinctive loss of SUZ12 was observed in the cfDNA derived from a PN patient, which was detected 25 months before the clinical diagnosis of MPNST, highlighting the predictive potential of liquid biopsies for identifying malignant transformation at early stages [80,87].